Benzinga | Dec 21, 2021 06:50AM EST

Barclays Maintains Overweight on Tenet Healthcare, Raises Price Target to $87

Barclays analyst Sarah James maintains Tenet Healthcare (NYSE:THC) with a Overweight and raises the price target from $81 to $87.